Diagnostic timeliness in adolescents and young adults with cancer: a cross-sectional analysis of the BRIGHTLIGHT cohort Annie Herbert, PhD, Prof Georgios Lyratzopoulos, MD, Prof Jeremy Whelan, MD, Rachel M Taylor, PhD, Julie Barber, PhD, Prof Faith Gibson, PhD, Lorna A Fern, PhD The Lancet Child & Adolescent Health Volume 2, Issue 3, Pages 180-190 (March 2018) DOI: 10.1016/S2352-4642(18)30004-X Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
Figure 1 Outcome definitions and their relation to key aspects of the diagnostic process Relevant survey items and data sources used to define each outcome (A–C) are detailed in the appendix. A&E=accident and emergency department. GP=general practitioner. The Lancet Child & Adolescent Health 2018 2, 180-190DOI: (10.1016/S2352-4642(18)30004-X) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions
Figure 2 Adjusted odds ratios of (A) patient interval >1 month and (B) three or more prereferral GP consultations, by cancer site Error bars denote 95% CI. GP=general practitioner. Bone tumours=osseous and chondromatous neoplasms, Ewing's tumour, and other neoplasms of bone. CNS=CNS and other intracranial and intraspinal neoplasms. Germ-cell tumours=germ-cell and trophoblastic neoplasms. The Lancet Child & Adolescent Health 2018 2, 180-190DOI: (10.1016/S2352-4642(18)30004-X) Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Terms and Conditions